Discussion of a Large Interventional Trial in Heart Failure with Preserved Ejection Fraction

This chapter delves into the details of the pivotal reduce LAP2 trial that focused on heart failure patients with preserved ejection fraction, revealing insights on exercise invasive hemodynamics and the outcomes of the trial where patients were randomized to receive an atrial shunt device or a sham control.